(S)-N-(4-(2,5-Dioxooxazolidin-4-yl)butyl)-2,2,2-trifluoroacetamide, 95.0%, 50g

2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)aniline>98.0%(GC)1g

1-(tert-Butoxycarbonyl)-3,3-difluoropiperidine-4-carboxylic acid, 95.0%, 1g

1-BOC-3-(HYDROXYMETHYL)-3-(TRIFLUOROMETHYL)PYRROLIDINE, 95.0%, 100mg

cis-N-(tert-Butoxycarbonyl)-4-hydroxy-D-proline>98.0%(HPLC)(T)5g

2-Amino-4-bromo-3,6-difluorobenzoic acid, 98%, 500mg

8-ethyl-4-(pyridine-3-carbonyl)-1-oxa-4,8-diazaspiro[4.5]decane-3-carboxylic acid, 95.0%, 1g

(4-(Acetoxymethyl)phenyl)boronic acid, 95.0%, 1g

Ethyl (S)-(+)-3-(2,2-dimethyl-1,3-dioxolan-4-yl)-2-propenoate, 95.0%, 1g

(S)-3-(Pyrrolidin-2-yl)pyridine dihydrochloride, 95.0%, 1g

(1S,10R,11S,14S,15S)-15-methyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-2(7),3,5-triene-5,14-diol, 97.0%, 1g

3-Chloropyridazin-6-yl hydrazine, 98.0%, 5g

Methyl perfluoroundecanoate, 96.0%, 5g